UPDATE 1-EU agency backs new drugs from J&J, Lilly and Takeda
March 21, 2014 at 09:02 AM EDT
LONDON, March 21 (Reuters) - European regulators have recommended approval of new pills for hepatitis C and diabetes from Johnson & Johnson and Eli Lilly, together with Takeda's injectable drug for bowel disorders.